Table 1.
Description of included studies.
|
| |||||||
|---|---|---|---|---|---|---|---|
| AUTHOR (YEAR) | COUNTRY | CONDITION OR RISK FACTOR | OUTCOME EXTRACTED | STUDY SETTING | INTERVENTION | RECOMMENDATIONS ACCEPTED BY PHYSICIAN | METHOD OF COLLABORATION |
|
| |||||||
| Albsoul-Younes, 2011 | Jordan | Hypertension | Change in BP | Co-location- unclear | Patient education and counselling, assessing medication regimen (noted patient medication history), adherence assessment, physical assessment. | 65 (101/161) | Verbal: face to face – unclear |
|
| |||||||
| Aguiar, 2018 | Brazil | Type 2 Diabetes | Change in BP, LDL, HbA1c | Separate | Patient education and counselling, assessing medication regimen, adherence assessment. | Not documented | Unclear |
|
| |||||||
| Amariles, 2012 | Spain | CVD | Change in BP, TC | Separate- unclear | Patient education and counselling, assessing medication regimen, physical assessment. | Not documented | Unclear |
|
| |||||||
| Anderegg, 2018 | United States of America | Type 2 Diabetes and Chronic Kidney Disease | Change in BP | Co-location | Patient education and counselling, assessing medication regimen, individualised care plan. | Not documented | Verbal or by electronic communication |
|
| |||||||
| Bogden, 1997 | United States of America | Hypercholesterolemia | Change in TC | Co-location | Patient education and counselling, assessing medication regimen, physical assessment (were done but not clear if it was by pharmacist). | 90 (167/186) | Verbal: face to face – unclear |
|
| |||||||
| Bogden, 1998 | United States of America | Hypertension | Change in BP | Co-location | Patient education and counselling, assessing medication regimen, physical assessment (were done but not clear if it was by pharmacist). | 93 (150/162) | Verbal: face to face – unclear |
|
| |||||||
| Borenstein, 2003 | United States of America | Hypertension | Change in BP | Separate | Patient education and counselling, assessing medication regimen, adherence assessment, physical assessment. | Not documented | Verbal: phone |
|
| |||||||
| Carter, 1997 | United States of America | Hypertension | Change in BP | Separate but in the same building | Patient education and counselling, assessing medication regimen, adherence assessment. (questioned about adherence), physical assessment. | Not documented | Verbal: mostly face to face but some over the phone (immediate) and written feedback too |
|
| |||||||
| Carter, 2008 | United States of America | Hypertension | Change in BP | Co-location | Patient education and counselling, assessing medication regimen, adherence assessment, (some, not all allowed) independent prescribing, physical assessment. | 96 (256/267) | Verbal: face to face |
|
| |||||||
| Carter, 2009 | United States of America | Hypertension | Change in BP | Co-location | Assessing medication regimen, physical assessment. | 96 (742/771) | Verbal: face to face |
|
| |||||||
| Carter, 2015 | United States of America | Hypertension | Change in BP | Co-location | Patient education and counselling, assessing medication regimen, adherence assessment, physical assessment. | Not documented | Mostly verbal: face to face, some written: email |
|
| |||||||
| Choe, 2005 | United States of America | Type 2 diabetes | Change in HbA1C | Co-location | Patient education and counselling, assessing medication regimen, physical assessment (upon need). | Not documented | Verbal: face to face |
|
| |||||||
| Ebid, 2020 | Egypt | Type 2 Diabetes | Change in LDL, HDL, HbA1c, BMI | Co-location | Patient education and counselling, assessing medication regimen, physical assessment, adherence assessment. | Not documented | Unclear |
|
| |||||||
| Fornos, 2006 | Spain | Type 2 diabetes | Change in BP, TC, LDL, HDL, TRIG, HbA1C, BMI | Separate | Patient education and counselling, assessing medication regimen, physical assessment, adherence assessment. | Not documented | Unclear |
|
| |||||||
| Geurts, 2016 | Netherlands | CVD | Change in BP, TC, LDL, HDL, HbA1C, BMI | Separate | Assessing medication regimen, physical assessment. | Not documented | Written: webbased pharmaceutical care plan tool |
|
| |||||||
| Hammad, 2011 | Jordan | Metabolic syndrome | Change in BP, HDL, TRIG, WEIGHT AND CM | Co-location | Patient education and counselling, assessing medication regimen, adherence assessment (?), physical assessment. | 70 (128/182) | Verbal |
|
| |||||||
| Hirsch, 2014 | United States of America | Hypertension | Change in BP, LDL, HDL | Co-location | Patient education and counselling, assessing medication regimen (noted patient medication history) adherence assessment, physical assessment, independent prescribing. | Not documented | physician was always present in the medical practice during the pharmacist clinic visits and was available for consultation as needed. |
|
| |||||||
| Hunt, 2008 | United States of America | Hypertension | Change in BP | Co-location | Patient education and counselling, assessing medication regimen, adherence assessment, physical assessment, independent prescribing. | Not documented | Written: emr (note documented and forwarded to PCP for approval and signature, verbal: face to face – not clarified (if needed) |
|
| |||||||
| McKenney, 1973 | United States of America | Hypertension | Change in BP | Separate | Patient education and counselling, assessing medication regimen, adherence assessment, physical assessment. | 100 (37/37) | written and verbal |
|
| |||||||
| Odegard, 2005 | United States of America | Type 2 diabetes | Change in HbA1C | Co-location | Patient education and counselling (?), assessing medication regimen, adherence assessment, physical assessment (?). | Not documented | EMR |
|
| |||||||
| Rothman, 2005 | United States of America | Type 2 diabetes (poorly controlled) | Change in BP, TC, HbA1C, WEIGHT | Co-location | Patient education and counselling, assessing medication regimen, physical assessment, independent prescribing (with approval of PCP). | Not documented | Written (results shared and written approval for medication change) & verbal: face to face (could be in the consult with the physician) or phone (could call them for approval) |
|
| |||||||
| Scott, 2006 | United States of America | Type 2 diabetes | Change in BP, LDL, HDL, HbA1C, WEIGHT AND BMI | Co-location | Patient education and counselling, assessing medication regimen, adherence assessment (?), physical assessment, independent prescribing (?). | Not documented | not specified |
|
| |||||||
| Siaw, 2017 | Singapore | Type 2 Diabetes | Change in BP, LDL, HbA1c, costs | Co-location | Patient education and counselling, assessing medication regimen, physical assessment, optimising medication dosing and frequency. | Not documented | Written |
|
| |||||||
| Simpson, 2011 | Canada | Type 2 diabetes patients with hypertension | Change in BP, TC, LDL, HDL, TRIG, HbA1C, BMI | Co-location | Patient education and counselling, assessing medication regimen, adherence assessment, physical assessment. | Not documented | Verbal |
|
| |||||||
| Sookaneknun, 2004 | Thailand | Hypertension | Change in BP | Separate | Patient education and counselling, assessing medication regimen, adherence assessment, physical assessment. | 47 (96/206) | Written: letter and medical record note |
|
| |||||||
| Tobari, 2010 | Japan | Hypertension | Change in BP, BMI, SMOKING CESSATION | Co-location | Patient education and counselling, assessing medication regimen adherence assessment, physical assessment. | Not documented | EMR and verbal (if necessary): phone or face to face |
|
| |||||||
| Zillich, 2005 | United States of America | Uncontrolled hypertension | Change in BP | Separate | Patient education and counselling, assessing medication regimen, adherence assessment, physical assessment. | 75 (43/57) | Written: EMR and verbal: phone |
|
| |||||||